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Abstract
The skin is the biggest structure of the body, and it plays a significant role in maintain-
ing the unity of the body environment. The skin is important for the endurance of the 
organism as an outer coat for the thermal regulation and hydration preservation. With 
the intention of helping these significant utilities, the skin continually experiences regen-
eration and holds the capability to overhaul wound by repair and regeneration of several 
kinds of skin stem cells. Noteworthy, development has been accomplished throughout 
the recent times in the generation of engineered skin alternates which imitate human 
skin cells in vitro for replacement or modeling. Conversely, existing new skin alterna-
tives do not reinstate completely the healthy skin anatomy and suffer from deficiency of 
natural supplements in skin covering, sebaceous glands, hair follicles, and sweat glands. 
Improvements in stem cell biology and skin morphogenesis show significant potentials 
to evidently advance the engineering of skin replacements which would preferably be 
vague from normal skin. This chapter reviews these developments in the in vivo and in 
vitro techniques of engineered and manufactured skin scaffold biomaterials.
Keywords: skin tissue engineering, scaffolds, skin, skin alternates, in vitro skin models, 
in vivo skin models, biomaterials, skin regeneration, skin renewal
1. Introduction
Tissue engineering is growing as a novel area in biomedical engineering which purposes 
to redevelop newfangled material for substituting problematic or injured tissues. In order 
to accomplish this, not only is a basis of cells necessary but also a simulated extracellular 
matrix (ECM) that the cells which may be reinforced should exist. Human skin signifies 
about one-tenth of the body form, and injuries like physical distress, infection, burn, dis-
ease, or operation to a portion of this main organ carry intense penalties. Tissue engineering 
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of skin substitutes signifies a potential foundation of improved treatment in fighting acute 
and chronic skin wounds. Currently, there are no significant prototypes of engineered skin 
which entirely duplicate the composition, structure, organic constancy, or visual environment 
of healthy skin. Skin alternates should carry some important physiognomies that comprise 
being simple to use and implement to the wound location; deliver vital blockade utility with 
suitable aquatic fluidity; be willingly adherent; have fitting corporeal and mechanical pos-
sessions; experience regulated deprivation; be disinfected, nontoxic, and nonantigenic; and 
induce negligible inflammatory effect. Moreover, they should join to the congregation with 
nominal damaging and agony and ease angiogenesis, whereas yet being cost operative. The 
eventual aim of tissue engineering is to gratify most if not all of these standards when creating 
original, clever skin replacement [1].
2. Structural and progressive provisions
The skin covers epidermal and dermal sheets pervaded via a multifaceted vascular and ner-
vous system. The hypodermis is located underneath, made by moveable linking tissue and 
fat. Epidermal basal cells and stem cells existing in the basal layer and hair follicles are in 
control of an unremitting progression of epidermal regeneration. Additional cell varieties that 
exist in the epidermis comprise melanocytes, Langerhans cells, and Merkel cells [2].
The dermis carries two stratums: a superior papillary layer carrying a reedy organization of 
collagen fibers and a dense inferior reticular layer with profuse collagen fibers similar to the 
superficial of the skin. The dermal extracellular matrix is made mostly of collagen, elastin, and 
reticular fibers. The key constituent of the dermis is the fibroblasts that deliver continuous 
excretion of the collagen and proteoglycan matrix [2].
Fetal wound repair shows a lack of scarring and fibrosis. This progression is categorized via 
negligible irritation and renewal of healthy collagen deposition and skin adnexa. The devel-
opment dynamic outline in fetal renewing skin is significantly diverse from the adult one, 
being described via advanced intensities of transforming growth factor (TGF)-β3 and minor 
stages of platelet-derived growth factor (PDGF), TGF-β1, and TGF-β2 [2].
3. Aims of skin tissue engineering
Tissue-contrived skin is a noteworthy improvement in the arena of wound healing. It has 
primarily been advanced related to the limits linked with the utilization of autografts and 
allografts where the contributor site agonizes from aching, contamination, and blemishing. 
Lately, engineered skin substitutes have been covering extensive submission, particularly in 
the circumstance of injuries, where the main preventive issue is the obtainability of autolo-
gous skin. The expansion of an imitated skin enables the action of patients with burns and 
several skin-associated disorders [2]. The existing review contributes an inclusive outline of 
the improvements and upcoming forecasts of skin alternates for tissue overhaul and renewal.
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4. Current skin substitutes
Autologous keratinocytes may be obtained and cultivated into interconnected layers of the 
epithelium which may be displaced onto big skin deficiencies on the suffering individual. 
Clonogenic keratinocytes, defined as holoclones, may be obtained from the skin and consecu-
tively proliferated in culture for more than 140 replications and have revealed to be bona fide 
multipotent stem cells founded on their aptitude to renovate manifold lines in the skin [3, 4].
These embedded stem cells inside of these epithelial expanses provide repair and regen-
eration of the epidermis. Developing the epidermal stem cells over fibrin environments or 
allogeneic dermis has established to be beneficial. The funding materials have significantly 
enhanced the receiving amounts of the implants, advanced the affluence of managing and 
operation of the implants, and reduced the wound refutation and scarring. Cultivation of 
autologous epidermal stem cells simplifies to obtain large epithelial areas for transfer from a 
minor skin biopsy; therefore, this method needs more than a few weeks [5].
Mounting the stem cells on a substance drops the period necessary to brand outsized epithe-
lial layers from a minor skin biopsy for the epithelia on the material which does not neces-
sitate to attain full confluence of the previous replacement. Furthermore, epidermal stem cells 
on fibrin environments or allogeneic dermis converse the capability to renew the usual rolled 
dermal/epidermal connection and the artificial ration of the dermis, named the papillary der-
mis. Nevertheless, these epidermal stem cell implants lack renovation of a complete prac-
tical skin. Epidermal adjuncts, containing hair follicles, sebaceous glands, or sweat glands, 
are not redeveloped after transferring these implants of epidermal stem cells, signifying that 
multifaceted epithelial and mesenchymal connections are essential to generate additions. 
Additionally, the implantations do not reinstate the automated possessions or visual form 
of the novel skin. Improvements in stem cell biology and skin morphogenesis have the pro-
spective to expand the manufacturing of the skin that may interchange the typical utility and 
esthetics of healthy skin [5].
5. Skin stem cells
Up to now, scientists have recognized numerous diverse sorts of skin stem cell covering epi-
dermal stem cells, hair follicle stem cells, melanocyte stem cells, mesenchymal stem cells, and 
recently identified human newborn foreskin stem cells. Epidermal stem cells are in charge for 
routine regeneration of the dissimilar stratums of the epidermis. These stem cells exist in the 
basal layer of the epidermis [6]. Hair follicle stem cells safeguard continuous renewal of the 
hair follicles. They can also restore the epidermis and sebaceous glands in case of injury. Hair 
follicle stem cells originated through the hair follicles [7].
Melanocyte stem cells are in control of melanocyte revival which is a kind of pigment cell. 
Melanocytes generate the pigment melanin and so carry a significant part in skin and hair fol-
licle pigmentation. It is not yet clear where these stem cells are located [8]. Studies also indicate 
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another type of stem cell, known as mesenchymal stem cells, which can be established in the 
dermis and hypodermis. Mesenchymal stem cells conquer lymphocyte production in vitro 
and extend skin graft endurance in vivo [9].
Another stem cell that resides in the skin is recently established and named as human new-
born foreskin stem cells. They carry pluripotency, and they are capable to turn into different 
cell types. They show fibroblastic shape; however, they express both mesenchymal stem cell 
markers and some of the hematopoietic stem cell markers [10].
6. In vivo applications
Autologous skin transfer is now the scientific main protocol for full-breadth skin injuries 
covering burn damages. Before grafting, primary editing is a significant portion of the han-
dling of burn wounds, as skin temperature-denatured proteins have to be detached to avoid 
numerous difficulties like contamination, manifold organ impairment condition, hypertro-
phic mutilation development, unrestrained inflammatory reaction, or infection with patho-
genic microorganisms. Microbes could utilize the eschar as a basis of nutriments and are 
particularly damaging to seriously burnt individual, as this damage also triggers a provi-
sional destruction of cell-related and humoral immunity [11].
Autologous split skin grafts (SSGs) are reaped with a dermatome which separates the epider-
mis and an artificial portion of the dermis. Residual epidermal cells in the enduring dermis of 
the SSG giver site will recreate an epidermis. Subsequent to the submission of an SSG to a full-
width wound, its vessels unite with the capillary system in the removed wound. This “graft 
take” is vital for a correct source of nourishment and brings implant endurance. The divided 
skin contributor place patches up in 1 week and may be utilized for SSG collecting up to four 
times; though, continual reaping is linked with blemishing at the contributor sites in addition 
to long hospital visits. Furthermore, in the situation of a wider damage, contributor sites are 
tremendously restricted and might leave the individual with very small unharmed skin to 
produce sufficient autologous SSGs. An initial and enduring wound healing is wanted, as it 
outcomes in negligible or no scarring difficulties, poorer impermanence, and improved prac-
tical extended duration outcomes [12]. Oppositely, wound healing postponement is straightly 
relative to vigorous hypertrophic scarring. In order to indicate the difficulty of restricted SSG 
reaping sites, an interconnecting method is applied that expanses the implant and so may 
cope a superior wounded region at the expenditure of cosmetic and practical result [13].
Additional option is the usage of allografts, for a provisional deterrence of liquid loss or infec-
tion of the wound. Allografts integrate into serious injuries and deliver ache relief. Therefore, 
moral as well as protection matters endure, as the severe broadcast for virus-related illnesses 
and consistent disinfection methods cannot entirely eradicate the probability of infectious 
mediator conduction. When compared to autologous SSGs, a leading trouble of allografts is 
that they consent the patients for a long time with wounds likely to problems. Ultimately, 
allografts experience immunogenic refusal, and the location of wound requires to be enclosed 
with an autologous SSG. Deferred refusal may happen in people with wide injuries because 
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of their clinically repressed immune reaction and, nonetheless, finally may be activated via 
the extremely immunogenic epithelial cells of the allograft throughout its vascularization. 
Consequently, there is a countless requirement for a substitute that may deliver a more 
enduring clarification [13].
7. Tissue-engineered skin alternates
Manufactured cell free along with allogeneic cell comprising skin alternates delivers a con-
ceivable resolution to the difficulty of donor implant scarcity. The engineered skin alternatives 
propose defense from liquid loss and infection while transporting dermal matrix constituents, 
cytokines, and evolution elements to the wound bed, increasing usual host wound thera-
peutic answers. Bioengineered skin alternatives may be utilized as impermanent covers once 
wound damaged tissue up to there is an autograft accessible. Subsequent to assimilation, 
these assemblies persevere in the wound throughout healing or even afterward. Cell-free bio-
material-related skin alternates may be utilized in integration with autografts as a defensive 
cover over interconnected autografts to fund their income in addition to arouse the wound 
bed in the spaces or to expand implant engraftment in parts of pressure. Nevertheless, in con-
tradiction of autografts, tissue-engineered allogeneic skin implants may tolerate the danger of 
conveying like hepatitis B virus (HBV) or human immunodeficiency virus (HIV). One benefit 
over autologous in vitro engineered skin alternates is that they have decreased industrial 
prices [14].
In order to manufacture epidermal replacements, a skin biopsy of 2–5 cm2 must be picked 
up from the individual. This may be joined with the first debridement of the injured person. 
Consequently, the epidermis is detached from the dermis, and solitary keratinocytes are chem-
ically discharged and cultivated on mitotically incapacitated mouse fibroblasts (Figure 1). The 
utilized development media cover fetal calf serum and other essential additions; conversely, it 
is also likely to enlarge these cells in xenogeneic-free situations. There are numerous revisions 
analyzing epithelial allografts such as Celaderm; conversely, the efficiency and protection of 
these harvests have to be established in organized scientific trainings. Along with these cus-
tom-built concepts, there have been several laboratories manufacturing cultivated epithelial 
allografts. Allogeneic crops carry the benefit of abridged industrial charges equated to autolo-
gous crops. Yet, an inadequacy of both harvests is that they demonstrate deprived attachment 
levels that may bring the creation of wounds [15].
On behalf of the management of full-width burns, mutually the epidermal and the dermal 
layers of the skin require to be substituted, as the action with expanded epidermal (kerati-
nocyte) layers would end in a mediocre conclusion. In contradiction of cultured epidermal 
layers, engineered dermal concepts can inhibit wound shrinkage, and they deliver a better 
constancy. The dermal and epidermal counterparts should be submitted successively, as 
decent dermal vascularization via the debrided wound bed requires to be attained previously 
to submission of the epidermal stratum. There is an extensive diversity of advertised dermal 
concepts, both natural and artificial. Some of these alternates are chemical-treated allografts 
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such as Alloderm, deficient for cellular rudiments that are important for the immunogenic 
refusal [16]. Besides, Dermagraft contains human foreskin fibroblasts, expanded in a fission-
able polyglactin network. In these alternates, cells secrete extracellular matrix (ECM) proteins, 
a variation of growth factors and cytokines into the wound till they experience usual pro-
grammed cell death 1 or 2 weeks post-embedding [17].
The most progressive and refined concepts that are accessible for scientific utilization are 
alternates that imitate epidermal along with dermal sheets of the skin. Even though imitating 
the histo-architecture of healthy skin, the epidermal/dermal skin alternates would be thought 
as provisional structurally effective wound layers. Skin replacements deliver growth factors, 
cytokines, and ECM for host cells; control wound remedial; and may consequence in active 
pain relief. Main drawbacks are the elevated industrial charges and their insufficiency to heal 
the wound enduringly regarding to tissue refusal. The immunogenic acceptance of a host in 
the direction of allogeneic fibroblasts is controversially deliberated. There are different revi-
sions sustaining the theories that allogeneic fibroblasts are individual autologous keratino-
cytes and are passable for the creation of a perpetual epidermal-dermal skin alternate [18].
8. In vitro applications
Tissue-engineered human skin has been technologically advanced to replicate the main funda-
mental and practical features of normal skin. In this background, they allow not only the exami-
nation of essential procedures in the skin but also the risk valuation of several chemicals which 
are locally presented to the skin deprived of the necessity to utilize animal models. Outcomes 
obtained from experimentations showed in animal models are mostly restricted regarding the 
alterations in the metabolism and the functional architecture. In vitro tests in two-flat monolayer 
Figure 1. Representation of perspectives of skin tissue engineering. Primary keratinocytes, fibroblasts, and stem cells are 
obtained from human contributor tissues that are afterward in vitro expanded previously to seeding onto appropriate 
scaffold materials.
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cultivation of human cells are also of nominal significance because of the absence of multifaceted 
cell-cell and cell-ECM connections [18]. Conversely, manufactured skin alternates may eliminate 
these difficulties via utilizing human cells which are organized in a 3D physical background, let-
ting the interface of the dissimilar cell sorts with one additional and nearby matrix [12].
Presently, skin alternatives are utilized in pharmaceutical investigation and in rudimentary 
examination. In these experimentations, skin alternatives attend as consistent archetypal 
schemes to classify irrigative, toxic, or destructive possessions of chemicals that arise into com-
munication with the human skin. In basic investigation, skin replacements may assist to explain 
essential progressions in the skin like the inducements that bring the creation of the epidermis, 
the cross talk among dissimilar cell sorts, the conservation of the stem cells, the development of 
wound healing, and the contamination with diverse types of pathogens. One excessive benefit 
of skin replacements is that the cellular arrangement is entirely manageable via the scientist. 
Therefore, a specific cell sort may be precisely combined or misplaced to regulate the signifi-
cance of the cell kind in the organic progression under investigation [12]. Skin tissue engineer-
ing may be examined with several in vitro models shown in Table 1.
Up to the present time, several sorts of skin alternatives have been established via dissimilar 
scientific groups. These skin alternatives may be categorized in two kinds. The primary one con-
tains keratinocytes applied on an artificial or collagen transporter faking only the human epider-
mis. The subsequent one contains a dermal sheet of human fibroblasts entrenched in numerous 
types of scaffolds [12].
9. Full-thickness in vitro models
Although the excessive mainstream of the skin alternates utilized in pharmaceutical investi-
gation is made of an epidermal sheet, these skin replacements could then be developed via 
the totaling of a dermal stratum covering fibroblasts. In this perspective, fibroblasts have only 
lately started to have more consideration. It was revealed that skin fibroblasts are distant 
from being uniform, and it was guessed that a few of the chronic wounds are related to an 
In vitro skin models Cell foundation References
Melanoma model Melanoma mesenchymal cells, 
fibroblasts, keratinocytes
[19]
UV radiation and phototype Keratinocytes, melanocytes, and 
fibroblasts
[20]
Wound healing model Fibroblasts and keratinocytes [21]
Psoriasis model Keratinocytes and fibroblasts [22]
Full-thickness model Epithelial sheath, fibroblasts, and 
keratinocytes
[23]
Ex vivo model No requirement of cells [24]
Table 1. In vitro skin tissue engineering models.
Tissue Engineering for Skin Replacement Methods
http://dx.doi.org/10.5772/intechopen.69905
321
alteration in the arrangement of the fibroblasts. It was displayed that fibroblasts clearly effect 
keratinocyte development in vitro, most probably because of the circumstance that these cells 
discharge solvable growth factors. In normal skin, the communication among fibroblasts and 
keratinocytes covers a key role in progressions like wound healing and the creation of the 
base membrane [1].
Utilizing skin alternatives, it was established that fibroblasts carry a vital part in the normal 
epidermal histology (Figure 2). In the absence of fibroblasts, the keratinocyte differentiation 
harshly changes and outcomes only in some sheets of extremely distinguished epithelial cells. 
Fascinatingly, keratinocytes carry a significant influence on the expansion of fibroblasts. This 
interface of epidermal and dermal cells is theorized because of a double paracrine tool that 
controls the development of keratinocytes and fibroblasts. Due to the theory, keratinocytes 
discharge IL-1 which rouses the skin fibroblasts to secrete keratinocyte growth factor (KGF) 
and granulocyte-monocyte colony-stimulating factor (GM-CSF) that sequentially effect the 
production of the keratinocytes. Moreover, dermal fibroblasts carry an important part in 
the renovation of the skin and in the tightening of acute wounds, and they can upturn the 
struggles of keratinocytes to toxic chemicals. Regarding the outcomes, one could determine 
that for obtaining significant data from toxicological in vitro experiments. Oppositely, epider-
mal replacements might be more appropriate for the determination of the diffusion constant 
through the skin. In monotonous in vitro diffusion studies, a specific part of skin alternates 
Figure 2. Utilization of skin fibroblast and keratinocyte for skin tissue engineering.
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divorces a contributor from an acceptor compartment. Collagen-related full-breadth skin 
alternates are not ultimate for that kind of tests since they do not cover the entire external part 
regarding to a low mechanic pliability, consequently finishing in open superiorities, over that 
the constituent under study may flexibly diffuse [12].
10. Skin gene therapy
The aptitude to hereditarily alter cells utilized to organize skin alternates allows ex vivo gene 
treatment methods to treat cutaneous illnesses and damages. Nonetheless, gene therapy 
stays as an unsatisfied potential of cell treatments with skin alternatives. Still, designated 
analysis of gene therapy in skin wounds has been accomplished recently. Initial models uti-
lizing overexpression of angiogenic growth factors with duplication-incompetent retroviral 
vectors established viability for constructive distribution of physically dynamic composites 
such as VEGF and PDGF, with a capacity for prompt wound healing in diminished wounds. 
Therefore, usage of retroviral gene transmission for the action of hematopoietic syndromes 
was linked with expansion of leukemia regarding the addition of mutagenesis, an outcome 
which has fundamentally banned the method from potential deliberation [25].
Parallel threats have been recognized in lentiviruses which have also decreased their forth-
coming custom in therapeutics. Replacements to viral tools have been industrialized that 
comprise plasmid transfection for expression of endogenous antimicrobial peptides like cat-
helicidin. Additional lately advanced methods such as gathered frequently interspaced short 
palindromic repeat (CRISPR) arrangement enable site-specific genome editing, greatly reduc-
ing the risk of insertional mutagenesis. In addition if gene therapies are managed in allogenic 
cells that are eradicated immunologically after a restricted period of time, then threats can be 
minimalized [25]. Nonviral skin gene transfer techniques are listed in Table 2 individually.
Transfer techniques Therapeutic mediator Submission reasons References
Direct injection Cytosine-phosphate-
guanine class C/
immunestimulatory 
sequence 
oligodeoxynucleotides
Tumor treatment [26]
Electroporation Antisense 
oligodeoxynucleotides
Wound healing [27]
Electroporation Chimeric RNA/DNA 
oligodeoxynucleotides
Hair follicle manipulation [28]
Topical Liposome-coated DNA Expressions of growth 
factors, cytokines, and 
hormones
[26]
Biolistic Naked DNA Immunization [29]
Table 2. Nonviral skin gene therapy methods.
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Induced pluripotent stem (iPS) cells may progress the competence of genome excision. The 
application of iPS cells includes deterioration of donor cells to a pluripotent state in vitro, 
growth of cell quantities, and adjustment of cell populace in the direction of a distinguished 
phenotype of concern. The arrangement of genetic adjustment methods, permitting accumu-
lation of healthy genes or alteration of mutated genes, with iPS knowledge delivers the apti-
tude to fix hereditary illnesses [25].
Skin alternates consequent to skin stem cells also carry a potential for practicable gene therapy 
for inactivating inherited illnesses of the skin, like epidermolysis bullosa. The epidermis is 
systematized into epidermal multiplying components which are self-renovated via at least one 
epidermal stem cell an propose that transport of epidermal stem cells from the basal stratum of 
the epidermis for gene treatment might consequence in enduring expression of the transgene 
[26]. Ex vivo transduced keratinocytes of holoclones have been revealed to have transgene 
expression which continues for more than 150 cell productions in culture and, more signifi-
cantly, have been publicized to express the transgene protein once implanted in epidermal 
stratums in vivo. Autologous epidermal stem cells obtained in culture via development of 
holoclones were retrovirally interacted with laminin 5 and were effectively relocated in people 
with junctional epidermolysis bullosa. The implants renewed a healthy epidermis at day 8, 
and the usual epidermis was preserved during 1 year of continuation [30].
11. Scaffold biomaterials in tissue engineering of the skin
In order to manufacture a body-compatible scaffold, it is important that the scaffold does not 
cause any acute or chronic response in the body. The scaffold must have a surface that is suit-
able for cell attachment so that it can replace the damaged tissue and help creating new tissue. 
If the biomaterial used in the making of the scaffold is biodegradable, newly regenerated 
tissue can replace the scaffold. Therefore, it is crucial that the scaffold is compatible with the 
skin tissue. For a scaffold to hold, it must have certain physical and mechanical properties and 
have a certain chemical structure in the surface. Researchers may use different biomaterials 
such as collagen, chitosan, hyaluronic acid, and poly(lactic acid) (PLA) in tissue engineering 
to build scaffolds [31].
11.1. Chitosan
Chitosan is one of the materials that is used in tissue engineering, which is used in wound 
healing. It is biodegradable, biocompatible, and nontoxic. In addition, it has hemostatic activ-
ity. It is also advantageous that chitosan is antibacterial. Chitosan can be used in stimulating 
collagen synthesis, and its electrostatic function can speed up the healing process. Sponges 
and gels that are made from chitosan are utilized in the healing process of full-width burn 
wounds. Chitosan loses its effect in acidic environments, and since wound healing is an acidic 
incident, cross-link agents may be used to stabilize chitosan structures [32].
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11.2. Hyaluronic acid
Hyaluronic acid is a lineal polysaccharide made of repeating disaccharide elements of N-acetyl-
glucosamine and n-glucuronic acid. Hyaluronic acid can be found in human skin and is known 
to be speeding up the healing process. Apart from these, it is observed that hyaluronic acid 
amount is increased in fetal skin and wounds in case of scar-free healing. Hyaluronic acid is a 
material with so much perks in scaffolding such as expanding the possibilities of cross-linking, 
delaying the biodegrading of materials, and more control over mechanical aspects of the pro-
cess. Also, hyaluronic acid offers more incorporation of cell adhesion ligands and growth fac-
tors in the making of scaffolds. Aquatic uptake ability, flexibility, and biocompatibility of the 
scaffold are some of the properties that are made possible and enhanced by HA [32].
11.3. Collagen
Collagen is a naturally found protein that can enhance the structural integrity. Collagen can 
be found in human skin tissue and mostly created by fibroblasts and myofibroblasts. In the 
body parts that are under stress and used often, for example, the skin, tendons and bones, 
collagen can be found in fibrils. One of the most common types of collagen which is also seen 
widely in scar tissues as well as the dermis, fasciae, and tendons is type I collagen. There are 
20 variations of collagens, and only types II, III, V, and XI can make up fibrils. Collagen is one 
of the most used materials that have been utilized in skin tissue engineering, and only recently 
it has been possible to create a model that can promote human capillary-like network [33].
It is an excellent material for scaffolding because of its ability to boost cell attachment, migra-
tion, proliferation, and differentiation. It is preferred in medical applications as a primary 
material since it is excellent in biocompatibility, biodegradability, and weak in antigenic-
ity. Scientific researches provided recombinant human collagen, and it proves to be a more 
dependable foundation for collagen which is not animal based. Human-based collagens are 
used in scaffolding, and they show promising results in efficiency for manufacturing skin, 
cartilage, and periodontal ligaments. Permeable collagen matrices with specific structural, 
biochemical, and biotic characteristics are interesting materials for tissue engineering, and 
introducing glycosaminoglycans may add to these characteristics because they are constitu-
ents of ECM proteins [34].
11.4. Silk
Silk is a biopolymer that is found in nature and has been used in medical applications for cen-
turies. It contains filament core protein, named fibroin, and a glue-similar coating with sericin 
proteins. Silk can be composed into many forms such as films, fibers, meshes, and sponges, 
and these forms have been used in many incidents, show great promise in supporting stem cell 
union, multiplying, and distinction in vitro, and are known to be boosting tissue repair in vivo. 
Skeletal structures such as bone, ligament, cartilage, and connective tissues such as the skin have 
been engineered using 3D silk fibroin scaffolds in stem cell-related tissue manufacturing [35].
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11.5. Fibrin glue
For some time now, fibrin glue has been used for medical applications such as plastic surgery 
and reconstructions as an adhesive compound. It is antibacterial, as well as it boosts hemo-
stasis. Apart from these, fibrin helps grow keratinocyte and fibroblast in vitro and in vivo 
and therefore promotes cellular movement in the wound. It has been observed that endog-
enous fibrin clots to create a temporary matrix in a purpose of promoting angiogenesis in the 
primary stage of wound healing. It is recognized that some growth factors are increased dur-
ing the wound healing process to promote angiogenesis. Vascular endothelial growth factor 
(VEGF) is one of these. Furthermore, if fibrin is preferred as a dermal substrate for an alterna-
tive of cultivated skin, it upsurges the discharge of VEGF, thus indorsing angiogenesis [34].
11.6. Artificial fragmental polymers
A few of the artificial fragmentable polymers utilized as permeable scaffolding constituents 
cover polyethylene glycol (PEG), poly(lactic acid) (PLA), polyglycolide (PGA), poly(lactic-
co-glycolic acid) (PLGA) [34], polycaprolactone (PCL), poly(d,l-lactic acid or d,l-lactide) 
(PDLLA), polyester elastomer (PEE) founded on polyethylene oxide (PEO), and polybutylene 
terephthalate (PBT). There are some synthetic polymers with biodegradable properties that 
are highly preferred as permeable scaffolding constituents such as polyethylene glycol (PEG), 
poly(lactic acid) (PLA), polyglycolide (PGA), poly(lactic-co-glycolic acid) (PLGA) [35], poly-
caprolactone (PCL) [17], poly(D,L-lactic acid or D,L-lactide) (PDLLA), polyester elastomer 
(PEE) based on polyethylene oxide (PEO), and polybutylene terephthalate (PBT) [37].
A superlative absorbent scaffold in skin tissue engineering should be the one which imitates 
the normal surroundings for skin development over suitable cell penetration, propagation, 
and differentiation. It should be biodegradable and penetrable to oxygen, aqua, and nutri-
tion interchange and must be defensive contrary to contamination and injury [38]. Up to the 
present time, there have been numerous kinds of absorbent scaffolds defined for skin tissue 
renewal, and most of them may be branded as fibrous permeable scaffolds. Nevertheless, 
there are some spongy or foamy scaffold sorts with advanced absorbency that may be utilized 
as operative concepts for skin renewal. Supreme of these scaffolds has collagen as a founda-
tion, and then keratinocytes or fibroblasts are planted into the scaffolds [39].
When choosing a porous scaffold to be used in skin tissue engineering, one must look for some 
properties and characteristics to create optimum conditions that resemble the usual back-
ground for skin development of the most over suitable cell permeation, creation, and distinc-
tion. The ideal scaffold also should safeguard against contamination and injury. There have 
been plenty of porous scaffolds with various forms to this day that are described for the regen-
eration of skin tissue, and most of these may be seen as fibrous absorbent scaffolds. Other than 
these scaffolds, there are also various types of spongy or foamy scaffolds which have higher 
porosity and can be used in skin regeneration. Collagen is the main ingredient in most of these 
porous scaffolds with keratinocytes or fibroblasts that are seeded into the scaffolds [36].
Scaffolds are designated in severe burns and skin deficiencies persuaded because of the elimi-
nation of tumors or skin implanting in patients experiencing necrotizing fasciitis owing to 
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bacterial contaminations [40]. Meanwhile, some original sponge scaffolds in arrangement 
with biomaterials like human keratin and polyvinyl alcohol/chitosan have also been described 
for their utilization as operative skin alternatives. Scaffolds have been used in medical appli-
cations such as acute burns and skin defects. Apart from these, some novel sponge scaffolds 
when used with biomaterials like human keratin and polyvinyl alcohol/chitosan have also 
been used since they are so effective as skin substitutes [1].
Nanofibrous scaffolds are extensively utilized for firming along with lenient tissue engineer-
ing submissions, and they also perform as tools for the regulated distribution of drugs and 
numerous biological particles in the arrangement of proteins and DNA [41]. Numerous usual 
and synthetic polymers have been applied for nanofiber constructions to generate fibrous scaf-
folds for biomedical applications [42]. These nanofibers are occasionally precisely functional-
ized via a basic interference or coating method or with superficial implanting polymerization 
by adding ligands and adhesive proteins on the nanofiber shallow. Combination of drugs, 
development factors, and genes straightly into the polymer elucidation throughout electro-
spinning is also a training for precise discharge possessions. Current methods for integrat-
ing therapeutic mediators or bioactive particles comprise coaxial electrospinning, suspension 
electrospinning, and alterations by external absorption or chemical conjugation [43]. In lieu of 
soft and hard tissue engineering and its submissions, nanofibrous scaffolds are widely used as 
well as deliver drugs in a controlled manner. Synthetic and natural polymers have been used 
for nanofiber manufactures to harvest rubbery scaffolds for biomedical presentations [44].
12. Discussion
The largest part of the human body is the skin. One of its key responsibilities is to protect the 
body from the environmental influences. When this shield is lost both acutely and chronically, 
it must repair itself to avoid termination of the life of its carrier. When the skin is wounded, re-
epithelialization of the wounded surface occurs [1, 2, 15–17]. Another important subject is that 
extensive wounds require an additional protection layer. This layer helps preventing desic-
cation and infections. It also guides cells to repair the wound and improve healing rates. This 
requirement led to the evolution of biologic and synthetic dressings and skin substitutes [14]. 
Wounds that occur due to massive burning made inventing different kinds of temporary and 
permanent skin alternatives necessary. This was needed because the patient could not repair 
its skin by itself. To be successful in long-term recovery, certain properties from both dermal 
and epidermal skin should be considered [9]. There is no example where an artificial skin is 
better than the original. Because of this, tissue engineers must focus their efforts on produc-
ing a universal skin that would be the best alternative in the shortest amount of time [13, 19].
A scaffold is used to create the three-dimensional structure for cell interactions and ECM 
production. It carries proper cytokines and growth factors to the target area [18]. It also sup-
ports the structure and functions of the newly formed tissue. There are certain criteria for a 
scaffold to provide all of the above [34, 36, 39, 41]: it should have a proper internal structure 
and surface that can support cellular behaviors such as adhesion, differentiation, and prolif-
eration [30]; it should have mechanical properties alike to the ones in the repair site [30]; and 
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it should be biocompatible. Its properties rely on the modifications that were applied to it 
and the nature of the biomaterial. Sponginess and pore scope of polymeric scaffolds display 
a critical role in tissue regeneration [38]. These considerations have been comprehensively 
deliberated and covered in different publications. Porous organization of scaffolds is impor-
tant with regard to their allowance of migration, adhesion, and multiplication and also diffu-
sion of wastes, oxygen, and nutrients [31]. It is certain that larger pores are used for supplying 
nutrients and removal of wastes. Small pores on the other hand provide surface area for cell 
adhesion. In order to generate dissimilar pore sizes and porosities, used techniques vary from 
salt discharge, modified lyophilization, phase separation, application of numerous freezing 
temperatures, application of various acoustic heaviness amplitudes, and application of differ-
ent electrospinning rates [36].
Reports show several types of scaffolds used in skin tissue regeneration. Even though there 
are some setbacks, they have been notably successful for repairing tissue and wound healing. 
They are also successful for delivering regular supply of nutrients and oxygen to cells, due 
to their variable porosities [36]. Mechanical strength and biocompatibility may be a subject of 
concern for fabrication of scaffolds, but composite and ceramic types have a promising future. 
Various biomaterials, both natural and synthetic, are used separately or in combination to cre-
ate scaffolds. Combinations of these materials overcome the issues with biocompatibility, bio-
degradability, and mechanical strength [33]. Collagen, cellulose, and chitosan are some of the 
examples for natural biomaterials [34]. They are found as either polysaccharide or proteins. 
These are highly biocompatible and easily degraded due to their similarities to the natural 
ECM. This makes them highly suitable for skin cell growth. If we look at synthetic biomate-
rials, some nanomaterial-type examples like polyvinylpyrrolidone (PVP), polycaprolactone 
(PCL) [41], poly-ethylene-glycol (PEG), poly lactic acid (PLA) [31, 35], and others are good 
for enhancing the strength of the scaffold. This requires more research and efforts toward 
the direction of composite scaffolds. An extensive knowledge of all the facts listed above will 
lead to producing highly effective and suitable scaffolds for skin tissue regeneration. There 
are many subjects in tissue engineering that should be overcome though such as scaffold 
interaction with cells, cellular proliferation and differentiation speed, and vascularization of 
the engineered tissues [37–39]. Rapid advancement of organ-on-chip technology, which led 
to “skin-on-chip” technology, has cleared the way for generating engineered skin for wound 
healing and drug testing [12]. The development of perfused chip-based bioreactors offers 
improvement of culturing conditions for skin organ cultures, as well as variable mechanical 
stress. Another advancement to note is microfluidic technologies, which are developed to 
create perfused skin-equivalent cultures and show a promise in the field of applying various 
drug molecules that are associated with skin tissue and wound healing [14, 17, 32, 33].
In vitro skin prototypes are used for recognizing skin destructive or poisonous materials 
and have been established to be beneficial implements for the examination of rudimentary 
evolving progressions as well as for the documentation of compulsive circumstances. Even 
though the enterprise of the epidermal and dermal stratum imitating in vitro skin alterna-
tives is almost ultramodern, there are obviously alterations among these replicas and natural 
in vivo skin [45]. One drawback of in vitro replacements is that they are not simply shaped, 
organized, or deposited. Practically, all in vitro skin is tailored and factory-made manually. 
A mechanized method would expressively decrease industrial charges and would propose 
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the comprehensive regulation of the procedure with a consistent result. The utilization of 
human keratinocyte derivative cell lines that are capable to cornify would support to lessen 
the charge of a skin replica even further and recover the expectedness of the last construct. 
Inopportunely, the mainstream of the presently obtainable cell lines is derivative of carci-
noma cells that lack the capacity to arrange a corneous layer; only lately, a novel cornifying 
cell line was presented [46]. Additional factor that is restraining the accomplishment of skin 
alternatives is their short lifetime. One method to accomplish a prolonged usability is the 
expansion of appropriate skin substitute conservation procedures as it had been done for 
dermal skin grafts [47].
The sustained development of iPS cell reprogramming widens a perspective to patient with 
precise stem cell foundations for tissue substitution. The competence of iPS production was 
lately established to be enriched with the utilization of keratinocytes [48]. Moreover, iPS can 
be produced from keratinocytes obtained from hair. Therefore, pulling a single hair from a 
person delivers only the initial substantial required to make iPS cells that may afterward be 
differentiated to custom tissue-related stem cells [49]. In different words, it can be thinkable 
for keratinocytes isolated from hair to be unswervingly reprogrammed to many skin stem 
cells deprived of an in-between iPS state. The aptitude to generate different skin stem cells 
which can be integrated into an engineered skin tissue will allow renewal of all of the complex 
cell types within the skin.
Recently identified human newborn foreskin stem cells also carry an enormous potential to 
differentiate into different cell types which may also eliminate the risk factors of gene trans-
fections in order to obtain stem cell properties. These cells have found to carry mesenchymal 
stem cell markers and some of the hematopoietic stem cell makers. Specific study of ours 
proved that they may be differentiated into chondrogenic, adipogenic, osteogenic, neuro-
genic, epithelial, and myogenic cells. In future prospects, they carry a potential to be used in 
tissue engineering models [10].
13. Future prospects
Future advances in in vitro skin alternatives should cover skin additions. The combination 
of sweat glands and hair follicles will assist to imitate a more accurate in vivo state and 
consequently involve a more precise experimental format. Many developments have been 
completed in the last decades for creating vascularized full-thickness in vitro skin models; 
nevertheless, the vascular-like structures could not be combined with an external vascular 
system wherein physiological shear circumstances are continued; thus, the growth of the in 
vitro vasculature was disallowed. The usage of more progressive biological scaffolds or syn-
thetic vasculature imitating structures might assist to eliminate these problems.
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